Sign in

CIK 0001730430

  • Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981795578
Phone
+1 781-431-9100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale EVP & Chief Legal Officer sold 49,941 shares at an average $19.10 ($953,975)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale Chairman & CEO sold 33,115 shares at $20.00 ($662,300)
  9. 4 Exercise or conversion SVP & Chief Medical Officer acquired 12,000 shares (option exercise)
  10. 4 Open-market sale SVP & Chief Medical Officer sold 32,280 shares at an average $18.48 ($596,487)
  11. 4 Open-market sale EVP & Chief Legal Officer sold 59 shares at $18.58 ($1,096)
  12. 4 Open-market sale SVP & Chief Medical Officer sold 11,316 shares at an average $18.29 ($207,011)
  13. 5 Insider Annual Insider Trading Report
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Exercise or conversion SVP & Chief Medical Officer acquired 8,000 shares (option exercise)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Exercise or conversion SVP & Chief Medical Officer acquired 10,000 shares (option exercise)
  20. 4 Derivatives Options or other derivatives

Page 17 of 20 · 386 filings